Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noradrenergic mechanisms in the prefrontal cortex

D J Nutt1, M D Lalies, L A Lione

  • 1Psychopharmacology Unit, School of Medical Sciences, University of Bristol, UK. David.J.Nutt@bristol.ac.uk

Journal of Psychopharmacology (Oxford, England)
|January 1, 1997
PubMed
Summary

Noradrenaline (NA) release in the prefrontal cortex (PFC) is key for its function. Antidepressants, antipsychotics, and novel imidazoline receptor ligands can modulate NA levels in the PFC, offering potential therapeutic benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human brain changes after first psilocybin use.

Nature communications·2026
Same author

Serotonergic psychedelics for depression: A comprehensive overview.

International review of neurobiology·2025
Same author

Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study.

Archives of suicide research : official journal of the International Academy for Suicide Research·2024
Same author

Psilocybin and Other Classic Psychedelics in Depression.

Current topics in behavioral neurosciences·2023
Same author

Canalization and plasticity in psychopathology.

Neuropharmacology·2022
Same author

Incidence of hyperoxia in trauma patients receiving pre-hospital emergency anaesthesia: results of a 5-year retrospective analysis.

Scandinavian journal of trauma, resuscitation and emergency medicine·2021

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Noradrenergic inputs to the prefrontal cortex (PFC) are crucial for regulating PFC function.
  • Understanding the pharmacological control of noradrenaline (NA) release in the PFC is essential for developing effective treatments for neurological and psychiatric disorders.

Purpose of the Study:

  • To review the pharmacological control of noradrenaline (NA) release in the prefrontal cortex (PFC).
  • To discuss how NA levels are modulated by antidepressant and antipsychotic drugs.
  • To introduce a new class of imidazoline receptor-selective compounds and discuss their potential clinical utility.

Main Methods:

  • Brain microdialysis was used to study NA release in the PFC.
  • Pharmacological agents, including antidepressants, antipsychotics, and novel compounds, were administered to modulate NA levels.

Related Experiment Videos

  • Extracellular NA levels in the PFC were measured.

    • Main Results:

    • Antidepressant and antipsychotic drugs modulate NA levels in the PFC.
    • Atypical antipsychotics like clozapine and risperidone may increase NA release, potentially contributing to their clinical benefits.
    • A new class of compounds selective for imidazoline receptors were shown to increase extracellular NA in the PFC.

    Conclusions:

    • Pharmacological modulation of NA release in the PFC is achievable through various drug classes.
    • Novel imidazoline receptor ligands demonstrate potential for increasing PFC NA levels and may represent a new therapeutic strategy.